TW200744674A - Controlled-release single layer tablet of alfuzosin - Google Patents

Controlled-release single layer tablet of alfuzosin

Info

Publication number
TW200744674A
TW200744674A TW095119791A TW95119791A TW200744674A TW 200744674 A TW200744674 A TW 200744674A TW 095119791 A TW095119791 A TW 095119791A TW 95119791 A TW95119791 A TW 95119791A TW 200744674 A TW200744674 A TW 200744674A
Authority
TW
Taiwan
Prior art keywords
weight
alfuzosin
single layer
controlled
layer tablet
Prior art date
Application number
TW095119791A
Other languages
Chinese (zh)
Inventor
Yih-Yih Lin
shao-ming Li
Original Assignee
Anchen Pharmaceuticals Taiwan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anchen Pharmaceuticals Taiwan Inc filed Critical Anchen Pharmaceuticals Taiwan Inc
Priority to TW095119791A priority Critical patent/TW200744674A/en
Publication of TW200744674A publication Critical patent/TW200744674A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An oral controlled release single layer tablet for the controlled release of an active ingredient into the proximal segments of the gastrointestinal tract, comprising: Alfuzosin in the amount of 1-10% by weight of the total tablet weight, a water swellable polymer in the amount of 30-80% by weight of the total tablet weight and a hydrophobic substance in the amount of 5-20% by weight of the total tablet weight.
TW095119791A 2006-06-05 2006-06-05 Controlled-release single layer tablet of alfuzosin TW200744674A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW095119791A TW200744674A (en) 2006-06-05 2006-06-05 Controlled-release single layer tablet of alfuzosin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW095119791A TW200744674A (en) 2006-06-05 2006-06-05 Controlled-release single layer tablet of alfuzosin

Publications (1)

Publication Number Publication Date
TW200744674A true TW200744674A (en) 2007-12-16

Family

ID=57914501

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095119791A TW200744674A (en) 2006-06-05 2006-06-05 Controlled-release single layer tablet of alfuzosin

Country Status (1)

Country Link
TW (1) TW200744674A (en)

Similar Documents

Publication Publication Date Title
EP2076183A4 (en) Devices and methods for endoluminal gastric restriction tissue manipulation, and drug delivery
WO2007109057A3 (en) Solid dosage form containing a taste masked active agent
IL202614A (en) Intravaginal drug delivery device, method of its preparation and uses thereof
MX2020011961A (en) Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances.
EP2329810A4 (en) Gastric retention drug delivery system, preparation method and use thereof
WO2010057082A3 (en) Diagnostic capsules, delivery/retrieval systems, kits and methods
EP1985283A4 (en) Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2012083017A3 (en) Controlled release oral dosage forms of poorly soluble drugs and uses thereof
WO2008122966A3 (en) A pharmaceutical composition of tacrolimus
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
WO2011101866A3 (en) Gastric retention formulation containing baclofen
WO2010062688A3 (en) Dosage form for insertion into the mouth
WO2007135193A3 (en) Sustained-release alcohol-resistant multimicroparticulate oral pharmaceutical form comprising anti-misuse means
WO2009117130A3 (en) Extended release forumulation containing a wax
WO2008044236A3 (en) Improved release of statins in the intestine
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
MX354416B (en) Nalbuphine-based formulations and uses thereof.
WO2011111027A3 (en) Oral dispersible delayed release tablet formulation
NZ594311A (en) Pharmaceutical composition comprising tamsulosin and solifenacin for oral administration
WO2010127205A3 (en) Fixed dose drug combination formulations
EP1983930A4 (en) Drug delivery system for retarding release of water soluble drugs
EP1753398A4 (en) Controlled release matrix pharmaceutical dosage formulation
WO2007016350A3 (en) Modified release tablet formulations with enhanced mechanical properties
WO2011090725A3 (en) Gastroretentive solid oral dosage forms with swellable hydrophilic polymer